The Impact of the Adequacy of Keratinized Mucosa on Peri-implant Tissue Health and Patient-reported Outcomes
1 other identifier
observational
150
1 country
1
Brief Summary
This study aims to conduct a cross-sectional study to compare the differences in clinical indices, patient-reported outcomes, and levels of inflammatory factors in peri-implant gingival crevicular fluid between sites with adequate (≥ 2 mm) and inadequate (\< 2 mm) keratinized mucosa after implant restoration, in order to explore the impact of the presence of keratinized mucosa on peri-implant soft and hard tissue health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 10, 2025
CompletedFirst Submitted
Initial submission to the registry
July 20, 2025
CompletedFirst Posted
Study publicly available on registry
August 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
August 15, 2025
August 1, 2025
1.4 years
July 20, 2025
August 8, 2025
Conditions
Outcome Measures
Primary Outcomes (7)
Width of Keratinized Mucosa, KMW
on the day of enrollment
Plaque Index(PI)
on the day of enrollment
Bleeding on Probing(BOP)
on the day of enrollment
Peri-implant Probing Depth(PPD)
on the day of enrollment
Marginal Bone Loss(MBL)
The X-ray examination will be completed on the day of enrollment
Patient Satisfaction
visual analogue scale \[VAS\] 0-10,e.g., not at all satisfied to perfectly satisfied
on the day of enrollment
Immunological parameters in peri-implant crevicular fluids(PICF)
PICF samples were collected from buccal aspects of implants after removing all supragingival plaque. The levels of IL-1β and PGE2 in PICF were measured using a sandwich ELISA kit.
The PICF will be collected on the day of enrollment
Study Arms (2)
inadequate keratinized mucosa
peri-implant width of keratinized mucosa less than 2 mm
adequate keratinized mucosa
peri-implant width of keratinized mucosa ≥ 2 mm
Interventions
Eligibility Criteria
Patients who have completed dental implant restoration(single crown or fixed bridge restorations) for at least 6 months and undergo routine follow-up examinations.
You may qualify if:
- Individuals aged 18 to 70 years (inclusive of 18 and 70 years), of any gender;
- Patients who have undergone dental implant restoration是(single crown or fixed bridge restorations) at the Stomatology Hospital, Zhejiang University School of medicine and have had their final restoration for at least 6 months;
- Patients who voluntarily participate and sign the informed consent form after being fully informed, and who cooperate with relevant examinations.
You may not qualify if:
- Patients who are unwilling to participate in the follow-up of this study for various reasons
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Stomatology Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310000, China
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 20, 2025
First Posted
August 15, 2025
Study Start
July 10, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
August 15, 2025
Record last verified: 2025-08